Study to Assess the Pharmacodynamic Effects of Repeated Oral Doses of SAR247799 on Endothelial Function in Male and Female Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 24 Dec 2019
Price : $35 *
At a glance
- Drugs SAR 247799 (Primary) ; Acetylcholine; Sildenafil
- Indications Coronary artery disease
- Focus Therapeutic Use
- Sponsors Sanofi
- 08 Jan 2019 Status changed from recruiting to completed.
- 29 Nov 2018 Planned End Date changed from 10 Dec 2018 to 21 Dec 2018.
- 29 Nov 2018 Planned primary completion date changed from 10 Dec 2018 to 21 Dec 2018.